At-Home Genetic Testing Market Report 2026

At-Home Genetic Testing Market Overview

• At-Home Genetic Testing market size has reached to $4.02 billion in 2025 • Expected to grow to $8.29 billion in 2030 at a compound annual growth rate (CAGR) of 15.5% • Growth Driver: Surge In Telehealth Adoption Fueling The Growth Of The Market Due To Increasing Convenience And Healthcare Accessibility • Market Trend: Integrated Health Memberships Drive Evolution of At-Home Genetic Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under At-Home Genetic Testing Market?

At-home genetic testing, or direct-to-consumer (DTC) genetic testing, refers to kits that allow individuals to collect their DNA samples, usually via saliva or a cheek swab, from the comfort of their home. This testing aims to analyze genetic information for insights into ancestry, health risks, traits, or carrier status of inherited conditions, enabling personalized health and lifestyle decisions. The main test types of at-home genetic testing include ancestry testing, health and wellness testing, disease risk assessment, carrier testing, and others. Ancestry testing refers to a type of genetic testing that analyzes a person's DNA to determine their ancestral origins and ethnic background. The technologies used in these tests include next-generation sequencing, polymerase chain reaction, microarray, and others, with commonly utilized sample types such as saliva, blood, cheek swab, urine, and others. The at-home genetic testing finds applications in personal use, clinical use, research use, pharmaceutical use, and nutritional use, distributed across various channels such as online platforms, retail pharmacies, and others.

What Is The At-Home Genetic Testing Market Growth Forecast?

The at-home genetic testing market size is expected to see rapid growth in the next few years. It will grow to $8.29 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing integration of genetic data with digital health platforms, rising demand for preventive healthcare solutions, expansion of personalized nutrition and fitness planning, growing regulatory clarity around DTC testing, advancements in genomic data analytics. Major trends in the forecast period include increasing adoption of direct-to-consumer genetic health kits, rising demand for ancestry and ethnicity analysis, growing use of pharmacogenomic testing, expansion of personalized wellness insights, enhanced focus on data privacy and consent.

Global At-Home Genetic Testing Market Segmentation

1) By Test Type: Ancestry Testing, Health And Wellness Testing, Disease Risk Assessment, Carrier Testing, Other Test Types 2) By Sample Type: Saliva, Blood, Cheek Swab, Urine, Other Specimens 3) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies 4) By Application: Personal Use, Clinical Use, Research Use, Pharmaceutical Use, Nutritional Use 5) By Distribution Channel: Online Platforms, Retail Pharmacies, Other Distribution Channels Subsegments: 1) By Ancestry Testing: Ethnicity Estimation, Genetic Heritage Mapping, Migration Pattern Analysis, Deep Ancestry Tracing 2) By Health And Wellness Testing: Nutrigenomics, Fitness and Exercise Response, Sleep Pattern Analysis, Stress and Behavioral Traits, Skin and Aging Traits 3) By Disease Risk Assessment: Cardiovascular Disease Risk, Cancer Risk Assessment, Neurological Disorder Risk, Autoimmune Disease Risk, Metabolic Disorder Risk 4) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Disease Screening, Sickle Cell Anemia Carrier Testing, Thalassemia Carrier Testing, Fragile X Syndrome Screening 5) By Other Test Types: Pharmacogenomics (Drug Response), Prenatal Genetic Testing, Pediatric Genetic Testing, Rare Disease Screening, Behavioral Trait Testing

What Is The Driver Of The At-Home Genetic Testing Market?

The growing adoption of telehealth is expected to propel the growth of the at-home genetic testing market going forward. Telehealth is the use of digital information and communication technologies such as computers, smartphones, and video conferencing to provide and manage healthcare services remotely. The growing adoption of telehealth is due to its convenience and ability to improve access to healthcare, especially for people in remote, rural, or underserved areas. At-home genetic testing supports telehealth by providing personalized genetic information that healthcare providers can use during virtual consultations. This data helps doctors tailor treatment plans, manage chronic conditions, and offer precise health recommendations remotely. For instance, in November 2025, according to the Australian Bureau of Statistics (ABS), an Australia-based government statistical agency, 22.5% of Australians used telehealth services in 2024–25. Among those who had a telehealth consultation, 90.3% reported they would use telehealth again if offered, up from 89.2% in 2023–24, indicating rising acceptance and continued adoption. Therefore, the growing adoption of telehealth drives the growth of the at-home genetic testing industry.

Key Players In The Global At-Home Genetic Testing Market

Major companies operating in the at-home genetic testing market are AncestryDNA, LetsGetChecked, Helix OpCo LLC, Everlywell Inc., Genos Inc., Vitagene Inc., Orig3n Inc., Mapmygenome India Limited, CircleDNA, EasyDNA Limited, African Ancestry Inc., Futura Genetics Ltd., Living DNA Ltd., Nebula Genomics Inc., TellmeGen S.L., Xcode Life Sciences Pvt Ltd., Color Health Inc., MyHeritage Ltd, FamilyTreeDNA (Gene By Gene Ltd), Color Genomics Inc, DNAfit, Pathway Genomics Inc.

Global At-Home Genetic Testing Market Trends and Insights

Major companies in the at-home genetic testing market are increasingly focusing on integrating innovative solutions such as health membership models to provide continuous, personalized preventive care. Health membership models are subscription-based programs that provide ongoing access to services such as advanced genetic testing, regular biomarker monitoring, and virtual clinician consultations, helping users track health risks continuously and receive personalized prevention plans. For instance, in November 2023, 23andMe, a US-based personal genomics company, launched 23andMe+ Total Health, a membership program offering clinical-grade exome sequencing of over 100 medically relevant genes linked to more than 55 health conditions, biannual testing for 55+ blood biomarkers, and virtual consultations with genetics-trained clinicians. This service is designed to support personalized prevention planning by integrating advanced genetic insights with ongoing monitoring and telehealth support, evolving at-home genetic testing from a one-time product into a continuous preventive health service.

What Are Latest Mergers And Acquisitions In The At-Home Genetic Testing Market?

In February 2025, Tempus AI Inc., a US-based health technology company, acquired Ambry Genetics Corporation for an undisclosed amount. With this acquisition, Tempus aims to strengthen its precision medicine capabilities by integrating Ambry Genetics’ expertise in genetic testing to enhance AI-driven diagnostics and patient care. Ambry Genetics is a US-based biotechnology company specializing in clinical-grade genetic testing.

Regional Outlook

North America was the largest region in the at-home genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the At-Home Genetic Testing Market?

The at-home genetic testing market consists of revenues earned by entities by providing services such as skin and aging DNA analysis, exome sequencing, and relationship testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The at-home genetic testing market also includes sales of whole genome sequencing kits, saliva collection kits, and hair sample kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the At-Home Genetic Testing Market Report 2026?

The at-home genetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the at-home genetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.